Correlation Between Eledon Pharmaceuticals and Inozyme Pharma

Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eledon Pharmaceuticals and Inozyme Pharma, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Inozyme Pharma.

Diversification Opportunities for Eledon Pharmaceuticals and Inozyme Pharma

0.35

Correlation Coefficient

Eledon Pharmaceuticals  Inozyme Pharma

Weak diversification

The 3 months correlation between Eledon and Inozyme is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Inozyme Pharma go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Inozyme Pharma

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 14.07 times less return on investment than Inozyme Pharma. But when comparing it to its historical volatility, Eledon Pharmaceuticals is 6.91 times less risky than Inozyme Pharma. It trades about 0.08 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  126.00  in Inozyme Pharma on May 6, 2025 and sell it today you would earn a total of  274.00  from holding Inozyme Pharma or generate 217.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	64.52%
Values	Daily Returns

Eledon Pharmaceuticals  vs.  Inozyme Pharma

Eledon Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Inozyme Pharma

Risk-Adjusted Performance

Good

Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly unfluctuating basic indicators, Inozyme Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eledon Pharmaceuticals and Inozyme Pharma

The main advantage of trading using opposite Eledon Pharmaceuticals and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.

The idea behind Eledon Pharmaceuticals and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.